nodes	percent_of_prediction	percent_of_DWPC	metapath
Buclizine—Cyclizine—SULT1E1—prostate cancer	0.214	0.249	CrCbGaD
Buclizine—Imatinib—PDGFRB—prostate cancer	0.0741	0.0863	CrCbGaD
Buclizine—Bifonazole—CYP17A1—prostate cancer	0.0724	0.0843	CrCbGaD
Buclizine—Imatinib—SLC22A1—prostate cancer	0.042	0.0489	CrCbGaD
Buclizine—Bifonazole—CYP19A1—prostate cancer	0.0369	0.0429	CrCbGaD
Buclizine—Imatinib—CYP3A5—prostate cancer	0.0339	0.0395	CrCbGaD
Buclizine—Azelastine—CYP3A5—prostate cancer	0.0329	0.0382	CrCbGaD
Buclizine—Azelastine—CYP2A6—prostate cancer	0.0318	0.037	CrCbGaD
Buclizine—Flunarizine—CYP2A6—prostate cancer	0.0311	0.0362	CrCbGaD
Buclizine—Bifonazole—CYP2E1—prostate cancer	0.0275	0.032	CrCbGaD
Buclizine—Bifonazole—CYP2C19—prostate cancer	0.0272	0.0317	CrCbGaD
Buclizine—Cinnarizine—CYP2A6—prostate cancer	0.0246	0.0286	CrCbGaD
Buclizine—Clemastine—CYP3A4—prostate cancer	0.0243	0.0283	CrCbGaD
Buclizine—Imatinib—CYP2C19—prostate cancer	0.0231	0.0269	CrCbGaD
Buclizine—Azelastine—CYP2E1—prostate cancer	0.0226	0.0263	CrCbGaD
Buclizine—Azelastine—CYP2C19—prostate cancer	0.0224	0.026	CrCbGaD
Buclizine—Azelastine—CYP1A1—prostate cancer	0.0223	0.0259	CrCbGaD
Buclizine—Flunarizine—CYP1A1—prostate cancer	0.0218	0.0254	CrCbGaD
Buclizine—Bifonazole—CYP3A4—prostate cancer	0.0173	0.0201	CrCbGaD
Buclizine—Cinnarizine—CYP1A1—prostate cancer	0.0172	0.0201	CrCbGaD
Buclizine—Imatinib—CYP3A4—prostate cancer	0.0147	0.0171	CrCbGaD
Buclizine—Azelastine—CYP3A4—prostate cancer	0.0142	0.0166	CrCbGaD
Buclizine—Loperamide—CYP3A4—prostate cancer	0.0107	0.0125	CrCbGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000145	0.00103	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000144	0.00103	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.000143	0.00102	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.000142	0.00101	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CALCA—prostate cancer	0.00014	0.000994	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CALCA—prostate cancer	0.000139	0.000991	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GHR—prostate cancer	0.000139	0.000988	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.000139	0.000987	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GHR—prostate cancer	0.000138	0.000985	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.000138	0.000983	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000137	0.000976	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000137	0.000973	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CXCL12—prostate cancer	0.000136	0.000971	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CXCL12—prostate cancer	0.000136	0.000968	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.000135	0.00096	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.000134	0.000957	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NRP1—prostate cancer	0.000133	0.000947	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NRP1—prostate cancer	0.000133	0.000944	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—ADRB2—prostate cancer	0.000129	0.000918	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—ADRB2—prostate cancer	0.000128	0.000915	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—TP53—prostate cancer	0.000126	0.000898	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—VAV3—prostate cancer	0.000126	0.000895	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—VAV3—prostate cancer	0.000125	0.000892	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PRKCQ—prostate cancer	0.000124	0.000886	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PRKCQ—prostate cancer	0.000124	0.000884	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.000124	0.000882	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GNRH1—prostate cancer	0.000124	0.00088	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—VIP—prostate cancer	0.000124	0.00088	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.000124	0.00088	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—VIP—prostate cancer	0.000123	0.000878	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GNRH1—prostate cancer	0.000123	0.000878	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—ITPR1—prostate cancer	0.000122	0.000868	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—ITPR1—prostate cancer	0.000122	0.000865	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—LPAR1—prostate cancer	0.00012	0.000853	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GRP—prostate cancer	0.00012	0.000853	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—LPAR1—prostate cancer	0.000119	0.00085	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GRP—prostate cancer	0.000119	0.00085	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PLCB2—prostate cancer	0.000119	0.000844	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—LRP2—prostate cancer	0.000119	0.000844	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PLCB2—prostate cancer	0.000118	0.000841	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—LRP2—prostate cancer	0.000118	0.000841	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—ADRB2—prostate cancer	0.000117	0.000833	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—ADRB2—prostate cancer	0.000117	0.000831	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CX3CL1—prostate cancer	0.000116	0.000828	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—P4HB—prostate cancer	0.000116	0.000828	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—P4HB—prostate cancer	0.000116	0.000825	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CX3CL1—prostate cancer	0.000116	0.000825	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—IL6—prostate cancer	0.000115	0.000822	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—VAV3—prostate cancer	0.000114	0.000813	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HIST1H2BG—prostate cancer	0.000114	0.000813	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—VAV3—prostate cancer	0.000114	0.00081	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HIST1H2BG—prostate cancer	0.000114	0.00081	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GRB7—prostate cancer	0.000113	0.000805	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PDE4D—prostate cancer	0.000113	0.000805	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PDE4D—prostate cancer	0.000113	0.000803	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GRB7—prostate cancer	0.000113	0.000803	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—ITPR1—prostate cancer	0.000111	0.000788	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—ITPR1—prostate cancer	0.00011	0.000786	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HIST1H4H—prostate cancer	0.00011	0.000785	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—CXCL8—prostate cancer	0.00011	0.000784	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HIST1H4H—prostate cancer	0.00011	0.000782	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—CXCL8—prostate cancer	0.00011	0.000782	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.00011	0.000781	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.000109	0.000779	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GNG5—prostate cancer	0.000108	0.000766	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GNG5—prostate cancer	0.000107	0.000764	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PTHLH—prostate cancer	9.37e-05	0.000667	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TGFBR1—prostate cancer	9.37e-05	0.000667	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PTHLH—prostate cancer	9.34e-05	0.000665	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TGFBR1—prostate cancer	9.34e-05	0.000665	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—AKR1C3—prostate cancer	9.22e-05	0.000656	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—AKR1C3—prostate cancer	9.19e-05	0.000654	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PRKACB—prostate cancer	9.17e-05	0.000653	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PRKACB—prostate cancer	9.14e-05	0.000651	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PPP3CA—prostate cancer	8.94e-05	0.000637	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—THBS1—prostate cancer	8.94e-05	0.000637	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—THBS1—prostate cancer	8.91e-05	0.000635	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PPP3CA—prostate cancer	8.91e-05	0.000635	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ANXA1—prostate cancer	8.81e-05	0.000627	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ANXA1—prostate cancer	8.78e-05	0.000625	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PRKCZ—prostate cancer	8.65e-05	0.000616	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PRKCZ—prostate cancer	8.62e-05	0.000614	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	8.45e-05	0.000602	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3CG—prostate cancer	8.43e-05	0.0006	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PARP1—prostate cancer	8.35e-05	0.000595	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FGFR4—prostate cancer	8.35e-05	0.000595	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PARP1—prostate cancer	8.33e-05	0.000593	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FGFR4—prostate cancer	8.33e-05	0.000593	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CALCA—prostate cancer	8.25e-05	0.000587	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CALCA—prostate cancer	8.22e-05	0.000586	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CXCL12—prostate cancer	8.06e-05	0.000574	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CXCL12—prostate cancer	8.03e-05	0.000572	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	7.68e-05	0.000547	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3CG—prostate cancer	7.65e-05	0.000545	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CASP9—prostate cancer	7.59e-05	0.00054	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CASP9—prostate cancer	7.57e-05	0.000539	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	7.43e-05	0.000529	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3CD—prostate cancer	7.41e-05	0.000527	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NGFR—prostate cancer	7.35e-05	0.000524	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PRKCQ—prostate cancer	7.35e-05	0.000524	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PRKCQ—prostate cancer	7.33e-05	0.000522	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NGFR—prostate cancer	7.33e-05	0.000522	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAP3K7—prostate cancer	7.27e-05	0.000517	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAP3K7—prostate cancer	7.24e-05	0.000516	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FGF10—prostate cancer	6.99e-05	0.000498	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FGF10—prostate cancer	6.97e-05	0.000496	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ADRB2—prostate cancer	6.91e-05	0.000492	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ADRB2—prostate cancer	6.89e-05	0.000491	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—JAK2—prostate cancer	6.82e-05	0.000486	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—JAK2—prostate cancer	6.8e-05	0.000484	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	6.79e-05	0.000484	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—MAP2K1—prostate cancer	6.77e-05	0.000482	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	6.75e-05	0.000481	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—VAV3—prostate cancer	6.74e-05	0.00048	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3CD—prostate cancer	6.73e-05	0.000479	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—VAV3—prostate cancer	6.72e-05	0.000479	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TGFBR2—prostate cancer	6.65e-05	0.000473	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TGFBR2—prostate cancer	6.63e-05	0.000472	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ITPR1—prostate cancer	6.54e-05	0.000466	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ITPR1—prostate cancer	6.52e-05	0.000464	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	6.48e-05	0.000461	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3CB—prostate cancer	6.46e-05	0.00046	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IGF1R—prostate cancer	6.25e-05	0.000445	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IGF1R—prostate cancer	6.23e-05	0.000444	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	6.23e-05	0.000443	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—CXCL8—prostate cancer	6.21e-05	0.000442	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—JAK2—prostate cancer	6.19e-05	0.000441	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—JAK2—prostate cancer	6.17e-05	0.00044	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—LPL—prostate cancer	6e-05	0.000427	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—LPL—prostate cancer	5.98e-05	0.000425	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—IL2—prostate cancer	5.95e-05	0.000424	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PDGFRB—prostate cancer	5.94e-05	0.000423	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—IL2—prostate cancer	5.93e-05	0.000422	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PDGFRB—prostate cancer	5.92e-05	0.000422	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	5.88e-05	0.000419	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3CB—prostate cancer	5.86e-05	0.000417	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ITGB3—prostate cancer	5.79e-05	0.000412	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ITGB3—prostate cancer	5.77e-05	0.000411	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	5.65e-05	0.000402	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CXCL8—prostate cancer	5.64e-05	0.000401	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ERBB3—prostate cancer	5.62e-05	0.0004	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FGFR2—prostate cancer	5.61e-05	0.000399	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ERBB3—prostate cancer	5.6e-05	0.000399	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FGFR2—prostate cancer	5.59e-05	0.000398	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—IL2—prostate cancer	5.4e-05	0.000385	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—IL2—prostate cancer	5.39e-05	0.000383	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TERT—prostate cancer	5.38e-05	0.000383	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TERT—prostate cancer	5.37e-05	0.000382	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HIF1A—prostate cancer	5.15e-05	0.000367	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HIF1A—prostate cancer	5.13e-05	0.000365	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—LEP—prostate cancer	5.03e-05	0.000358	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—LEP—prostate cancer	5.01e-05	0.000357	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CAV1—prostate cancer	4.98e-05	0.000354	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CAV1—prostate cancer	4.96e-05	0.000353	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—KDR—prostate cancer	4.92e-05	0.000351	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—KDR—prostate cancer	4.91e-05	0.000349	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ESR1—prostate cancer	4.8e-05	0.000342	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ESR1—prostate cancer	4.78e-05	0.00034	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—BAD—prostate cancer	4.68e-05	0.000333	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—BAD—prostate cancer	4.67e-05	0.000332	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—APC—prostate cancer	4.54e-05	0.000323	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	4.54e-05	0.000323	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—APC—prostate cancer	4.52e-05	0.000322	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	4.52e-05	0.000322	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—EGF—prostate cancer	4.48e-05	0.000319	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IRS1—prostate cancer	4.48e-05	0.000319	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IRS1—prostate cancer	4.47e-05	0.000318	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—EGF—prostate cancer	4.47e-05	0.000318	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GSK3B—prostate cancer	4.35e-05	0.00031	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GSK3B—prostate cancer	4.34e-05	0.000309	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—INS—prostate cancer	4.29e-05	0.000306	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—INS—prostate cancer	4.28e-05	0.000305	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CREBBP—prostate cancer	4.21e-05	0.000299	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CREBBP—prostate cancer	4.19e-05	0.000298	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IGF1—prostate cancer	4.15e-05	0.000296	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IGF1—prostate cancer	4.14e-05	0.000295	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—EGFR—prostate cancer	4.13e-05	0.000294	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—EGFR—prostate cancer	4.12e-05	0.000293	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	4.01e-05	0.000286	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	4e-05	0.000285	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	3.99e-05	0.000284	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	3.97e-05	0.000283	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	3.95e-05	0.000281	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	3.94e-05	0.000281	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	3.94e-05	0.00028	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	3.93e-05	0.00028	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—KRAS—prostate cancer	3.9e-05	0.000278	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—KRAS—prostate cancer	3.89e-05	0.000277	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FGF2—prostate cancer	3.82e-05	0.000272	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FGF2—prostate cancer	3.81e-05	0.000271	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NOS3—prostate cancer	3.76e-05	0.000268	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NOS3—prostate cancer	3.75e-05	0.000267	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—JAK2—prostate cancer	3.66e-05	0.000261	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—JAK2—prostate cancer	3.65e-05	0.00026	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	3.59e-05	0.000255	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	3.57e-05	0.000255	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MDM2—prostate cancer	3.57e-05	0.000254	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MDM2—prostate cancer	3.56e-05	0.000253	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ERBB2—prostate cancer	3.52e-05	0.000251	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ERBB2—prostate cancer	3.51e-05	0.00025	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	3.48e-05	0.000247	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	3.46e-05	0.000247	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CXCL8—prostate cancer	3.34e-05	0.000238	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CXCL8—prostate cancer	3.33e-05	0.000237	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	3.26e-05	0.000232	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	3.25e-05	0.000231	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	3.23e-05	0.00023	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	3.22e-05	0.000229	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CASP3—prostate cancer	3.2e-05	0.000228	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IL2—prostate cancer	3.19e-05	0.000227	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CASP3—prostate cancer	3.19e-05	0.000227	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IL2—prostate cancer	3.18e-05	0.000227	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—IL6—prostate cancer	3.18e-05	0.000226	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—IL6—prostate cancer	3.17e-05	0.000225	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CCND1—prostate cancer	3.11e-05	0.000222	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CCND1—prostate cancer	3.1e-05	0.000221	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	3.08e-05	0.000219	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	3.07e-05	0.000219	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MMP9—prostate cancer	3.02e-05	0.000215	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MMP9—prostate cancer	3.01e-05	0.000214	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	3.01e-05	0.000214	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PTEN—prostate cancer	3e-05	0.000214	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	3e-05	0.000214	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PTEN—prostate cancer	2.99e-05	0.000213	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—AKT1—prostate cancer	2.93e-05	0.000209	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	2.92e-05	0.000208	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—EP300—prostate cancer	2.86e-05	0.000204	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—EP300—prostate cancer	2.85e-05	0.000203	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SRC—prostate cancer	2.78e-05	0.000198	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SRC—prostate cancer	2.78e-05	0.000198	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—VEGFA—prostate cancer	2.71e-05	0.000193	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	2.7e-05	0.000192	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—STAT3—prostate cancer	2.69e-05	0.000191	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—STAT3—prostate cancer	2.68e-05	0.000191	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MYC—prostate cancer	2.5e-05	0.000178	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TGFB1—prostate cancer	2.49e-05	0.000177	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MYC—prostate cancer	2.49e-05	0.000177	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	2.48e-05	0.000177	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—EGFR—prostate cancer	2.44e-05	0.000174	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—EGFR—prostate cancer	2.43e-05	0.000173	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—KRAS—prostate cancer	2.31e-05	0.000164	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—KRAS—prostate cancer	2.3e-05	0.000164	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	2.12e-05	0.000151	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	2.11e-05	0.00015	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TP53—prostate cancer	2.05e-05	0.000146	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TP53—prostate cancer	2.04e-05	0.000145	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IL6—prostate cancer	1.88e-05	0.000134	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IL6—prostate cancer	1.87e-05	0.000133	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—AKT1—prostate cancer	1.73e-05	0.000123	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—AKT1—prostate cancer	1.73e-05	0.000123	CbGpPWpGaD
